Risk of Share-Value Dilution from the Exercise of Stock Acquisition Rights
First written in FY2020. 11 of 15 entries say "Materialised", first in FY2021. Latest entry: FY2026.
Japan PropTech moved to the "Worse" side of this theme in 2021, the same year as the typical company in this theme.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「As of the end of the fiscal year (30 June 2026), the number of potential shares represented by stock acquisition rights was 118,000, equivalent to 0.8% of the 14,412,440 issued shares.」
The number of remaining potential shares decreased from 170,000, or 1.2%, in the previous fiscal year to 118,000, or 0.8%. - FY2026-H1MaterialisedAnnual report
「1 July 2025–31 December 2025 14,000 14,374,440 1,120 731,248 1,120 701,248 (Note) Increase due to the exercise of stock acquisition rights.」
During the interim accounting period, 14,000 shares were issued upon the exercise of stock acquisition rights, bringing the total number of issued shares to 14,374,440. Dilution continued to occur in practice. - FY2025MitigatedAnnual report
「As of the end of the fiscal year (30 June 2025), the number of potential shares represented by stock acquisition rights was 170,000, equivalent to 1.2% of the 14,360,440 issued shares.」
The number of remaining potential shares decreased from 176,000 at the end of the previous fiscal year to 170,000, while the ratio remained at 1.2%. - FY2024MitigatedAnnual report
「As of the end of the fiscal year (30 June 2024), the number of potential shares represented by stock acquisition rights was 176,000, equivalent to 1.2% of the 14,354,440 issued shares.」
The number of remaining potential shares decreased from 191,000, or 1.3%, at the end of the previous fiscal year to 176,000, or 1.2%. During the year, 15,000 shares were issued upon the exercise of stock acquisition rights. - FY2024-Q3MaterialisedAnnual report
「1 January 2024–31 March 2024 14,000 14,354,440 1,120 729,648 1,120 699,648 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter, 14,000 shares were issued upon the exercise of stock acquisition rights, bringing the total number of issued shares to 14,354,440. Dilution continued to occur in practice. - FY2024-Q2MaterialisedAnnual report
「1 October 2023–31 December 2023 1,000 14,340,440 80 728,528 80 698,528 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter of the fiscal year, 1,000 shares were issued upon the exercise of stock acquisition rights, bringing the total number of issued shares to 14,340,440. - FY2023MaterialisedAnnual report
「As of the end of the fiscal year (30 June 2023), the number of potential shares represented by stock acquisition rights was 191,000, equivalent to 1.3% of the 14,339,440 issued shares.」
During the year, 73,000 shares were issued upon the exercise of stock acquisition rights, and dilution continued to occur in practice. The number of remaining potential shares was 191,000, or 1.3%. - FY2023-Q3MaterialisedAnnual report
「1 January 2023–31 March 2023 (Note) 15,000 14,313,440 1,200 726,368 1,200 696,368 (Note) Increase due to the exercise of stock acquisition rights.」
15,000 shares were issued upon the exercise of stock acquisition rights in the third quarter, bringing the total number of issued shares to 14,313,440. Dilution continued to occur in practice. - FY2023-Q2MaterialisedAnnual report
「1 October 2022–31 December 2022 18,000 14,298,440 1,440 725,168 1,440 695,168 (Note) Increase due to the exercise of stock acquisition rights.」
18,000 shares were issued upon the exercise of stock acquisition rights in the second quarter, bringing the total number of issued shares to 14,298,440. - FY2023-Q1MaterialisedAnnual report
「1 July 2022–30 September 2022 14,000 14,280,440 1,120 723,728 1,120 693,728 (Note) Increase due to the exercise of stock acquisition rights.」
14,000 shares were issued upon the exercise of stock acquisition rights in the first quarter, bringing the total number of issued shares to 14,280,440. - FY2022MaterialisedAnnual report
「As of the end of the fiscal year (30 June 2022), the number of potential shares represented by stock acquisition rights was 264,000, equivalent to 1.8% of the 14,266,440 issued shares.」
During the fiscal year, 40,000 shares were also issued upon the exercise of stock acquisition rights, leaving 264,000 potential shares, or 1.8%. - FY2022-Q2MaterialisedAnnual report
「1 October 2021–31 December 2021 (Note) 22,000 14,260,440 1,760 722,128 1,760 692,128 (Note) Increase due to the exercise of stock acquisition rights.」
22,000 shares were issued upon the exercise of stock acquisition rights in the second quarter, bringing the total number of issued shares to 14,260,440. - FY2022-Q1MaterialisedAnnual report
「1 July 2021–30 September 2021 (Note) 12,000 14,238,440 960 720,368 960 690,368 (Note) Increase due to the exercise of stock acquisition rights.」
12,000 shares were issued upon the exercise of stock acquisition rights in the first quarter, and potential shares continued to be converted into issued shares. - FY2021MaterialisedAnnual report
「As of the end of the fiscal year (30 June 2021), the number of potential shares represented by stock acquisition rights was 304,000, equivalent to 2.1% of the 14,226,440 issued shares.」
From May to June 2021, 412,000 shares were issued upon the exercise of stock acquisition rights, resulting in actual dilution of equity value. At the end of the period, 304,000 potential shares remained, representing 2.1%. - FY2020First statedAnnual report
「As of the end of the fiscal year (30 June 2020), the number of potential shares from stock acquisition rights was 360,000, equivalent to 6.1% of the total 5,883,720 shares issued.」
The exercise period for stock acquisition rights granted as incentives to officers and employees is also disclosed.